RBC Lifts Price Target on QuidelOrtho to $62 From $61, Keeps Outperform Rating
QuidelOrtho Appoints Lee Bowman as Chief Human Resources Officer
Why QuidelOrtho Stock Blasted 10% Higher Today
G-III Apparel Posts Upbeat Results, Joins NIO, Yext, Shoe Carnival And Other Big Stocks Moving Higher On Thursday
QuidelOrtho Rises as Craig-Hallum Upgrades on Earnings Power
Craig-Hallum Upgrades QuidelOrtho(QDEL.US) to Buy Rating, Raises Target Price to $57
Craig-Hallum analyst William Bonello upgrades $QuidelOrtho(QDEL.US)$ to a buy rating, and adjusts the target price from $40 to $57.According to TipRanks data, the analyst has a success rate of 60.9%
Express News | QuidelOrtho Corporation : Craig-Hallum Raises Target Price to $57 From $40
Express News | QuidelOrtho Corporation : Craig-Hallum Raises to Buy From Hold
Reasons to Retain QuidelOrtho Stock in Your Portfolio for Now
QuidelOrtho Expands in Infectious Disease Testing With New FDA Nod
QuidelOrtho Says FDA Approved Syphilis Assay on Disease-Testing Platform
VITROS Syphilis Assay Now Available on VITROS 3600 Immunodiagnostic System, VITROS 5600 and VITROS XT 7600 Integrated Systems in the U.S.
U.S. to Restart Free COVID Test Program as Cases Spike
QuidelOrtho Corporation (NASDAQ:QDEL) Surges 26% Yet Its Low P/S Is No Reason For Excitement
QuidelOrtho to Participate in Upcoming Investor Conferences
QuidelOrtho Price Target Maintained With a $61.00/Share by RBC Capital
QuidelOrtho Analyst Ratings
RBC Capital Maintains QuidelOrtho(QDEL.US) With Buy Rating, Maintains Target Price $61
RBC Capital analyst Conor McNamara maintains $QuidelOrtho(QDEL.US)$ with a buy rating, and maintains the target price at $61.According to TipRanks data, the analyst has a success rate of 43.0% and a
RBC Capital Reaffirms Their Buy Rating on QuidelOrtho (QDEL)
Jana Partners Top Buys and Sells in Q2